Medtronic Inc. (NYSE:MDT) tapped former St. Jude Medical executive Michael Coyle to be president of its cardiology division, after consolidating its many divisions into a pair of operating groups in August.
Coyle will lead one of those divisions, which includes the Minneapolis-based medical device monolith’s cardiac rhythm disease management, cardiovascular and Physio-Control businesses.
Medtronic said Coyle, most recently a management consultant, was president of SJM’s cardiac rhythm management division from 2001 to 2007. He was also president of St. Jude’s Daig Catheter division from 1997 to 2001, according to a press release.
In August, Medtronic reshuffled the deck, changing its corporate and management structures as part of is “One Medtronic” program. In addition to consolidating its various cardiology businesses under a single umbrella, the company united its spinal and biologics, neuromodulation, diabetes, and surgical technologies units under another.
Chris O’Connell, formerly president of the diabetes segment, was tapped to be the latter units president.
Medtronic posted net earnings of $868 million on sales of $3.84 billion during the second quarter, compared with net earnings of $547 million in $3.57 billion in sales during the same period last year.